The researches aim to study the effects of DHA (component of fish oil) on patients with
Primary Sclerosing Cholangitis (PSC). Our hypothesis is that DHA might reverse the problems
associated with PSC.
Phase:
Phase 1
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)